Real-world incidence of febrile neutropenia among patients treated with single-agent amrubicin: Necessity of the primary prophylactic administration of granulocyte colony-stimulating factor
Research output: Contribution to journal › Article › peer-review
3Scopus
citations
Fingerprint
Dive into the research topics of 'Real-world incidence of febrile neutropenia among patients treated with single-agent amrubicin: Necessity of the primary prophylactic administration of granulocyte colony-stimulating factor'. Together they form a unique fingerprint.